Xcelerate (OTCMKTS:XCRT) versus DaVita (NYSE:DVA) Critical Comparison

DaVita (NYSE:DVA) and Xcelerate (OTCMKTS:XCRT) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, dividends, risk, profitability, institutional ownership and earnings.

Profitability

This table compares DaVita and Xcelerate’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
DaVita	5.47%	-413.18%	4.70%
Xcelerate	N/A	N/A	N/A

Insider & Institutional Ownership

90.1% of DaVita shares are owned by institutional investors. 1.5% of DaVita shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Earnings and Valuation

This table compares DaVita and Xcelerate”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DaVita	$13.64 billion	0.77	$746.80 million	$9.91	15.77
Xcelerate	N/A	N/A	N/A	N/A	N/A

DaVita has higher revenue and earnings than Xcelerate.

Analyst Recommendations

This is a summary of current ratings and recommmendations for DaVita and Xcelerate, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DaVita	1	4	1	1	2.29
Xcelerate	0	0	0	0	0.00

DaVita currently has a consensus price target of $155.80, suggesting a potential downside of 0.30%. Given DaVita’s stronger consensus rating and higher possible upside, equities analysts plainly believe DaVita is more favorable than Xcelerate.

Risk and Volatility

DaVita has a beta of 0.99, suggesting that its stock price is 1% less volatile than the S&P 500. Comparatively, Xcelerate has a beta of 0.87, suggesting that its stock price is 13% less volatile than the S&P 500.

Summary

DaVita beats Xcelerate on 10 of the 11 factors compared between the two stocks.

About DaVita

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.

About Xcelerate

Xcelerate Inc. acquires engineering/patents and applies to early-stage medical technology companies. The company engages in the formulation, packaging and marketing of consumer health and beauty, and clinically tested skin care products; development of artificial intelligence and virtual health technology to assist patients; owning and licensing the rights to various forms of medical equipment. It also provides Ceramedx, a natural plant based therapeutic skin care product; Earth Science Beauty, which offers natural facial skincare targeted to specific skin types. The company was formerly known as Union Dental Holdings, Inc. and changed its name to Xcelerate Inc. Xcelerate Inc. was incorporated in 1996 is based in Mauldin, South Carolina.